Journal of Bacteriology & Parasitology

Market Analysis for International Conference on Chronic Disorder and Infectious Diseases

Durgesh Kumar Dwivedi Facility for Risk Assessment and Intervention Studies, Department of Pharmacology and Toxicology, National Institute of Pharmaceutical Education and Research, Punjab, India

Chronic Disorder 2020 welcomes attendees, presenters and exhibitors from all over the world to Berlin, Germany. We are delighted to invite you all to attend and register for the “International Conference on Chronic Disorder 2020” which is going to be held during November 23-24, 2020 Madrid, Spain

The organizing committee is gearing up for an exciting and informative conference program including plenary lectures, symposia, workshops on a variety of topics, poster presentations and various programs for participants from all over the world. We invite you to join us at the Chronic Disorder 2020, where you will be sure to have a meaningful experience with scholars from around the world. All members of Chronic Disorder 2020 organizing committee look forward to meet you in Berlin, Germany.

Why Berlin, Germany?

Berlin, Germany’s capital, dates to the 13th century. Reminders of the city's turbulent 20th-century history include its Holocaust memorial and the Berlin Wall's graphitized remains. Divided during the Cold War, its 18th-century Brandenburg Gate has become a symbol of reunification. The city's also known for its art scene and modern landmarks like the gold-colored, swoop-roofed Berliner Philharmonic, built in 1963.

Top Universities around the World:

• National Center for Tumor Diseases (NCT), Dresden, Germany

• Breast Center, Holweide Hospital, Cologne, Germany.

• National Center for Tumor Diseases (NCT) Heidelberg

• Charité Comprehensive Cancer Center

• Breast Cancer Research Centre, Rheinische Friedrich-Wilhelms-University of Bonn, Bonn, Germany

• Georg-August University, Gottingen, Germany

• International Agency for Research on Cancer, Lyon, France

• National Cancer Institute, Cairo University, Cairo, Egypt

• National Cancer Institute, Bethesda, MD, USA

• Haceteppe University Institute of Oncology, Ankara, Turkey

• Israel Cancer Association

• National University of Singapore

• Hong Kong University of Science & Technology

• Peking University

• The Chinese University of Hong Kong

• University of Hong Kong

Top Societies and Association around the World:

• American Cancer Society

• American Society for Radiation Oncology

• American Society of Paediatric Haematology/Oncology

• Association of Cancer Physicians

• Cancer Relief Society Nepal

• Cancer Society of Finland

• Cancer Society of New Zealand

• Breast Screen Australia Program

• Indonesian Society of Gynecologic Oncology

• International Gynecologic Cancer Society

• Iranian Society of Radiation Oncology

• Japanese Breast Cancer Society

• Thai Gynecologic Cancer Society

• Spanish Oncology Nursing Society

• Kuwait Cancer Control Centre

Chronic Disorder in Europe: Chronic diseases are the leading cause of mortality and morbidity in Europe, and research suggests that complex conditions such as diabetes and depression will impose an even larger burden in the future. Some years ago chronic diseases were considered to be a problem of the rich and elderly population. Today we know that within high-income countries, poor as well as young and middle-aged people are affected by chronic conditions. The economic implications of such diseases are also serious. Chronic diseases depress wages, earnings, workforce participation and labour productivity, as well as increasing early retirement, high job turnover and disability. Disease-related impairment of household consumption and educational performance has a negative effect on gross domestic product (GDP). As expenditure on chronic care rises across Europe, it takes up increasingly greater proportions of public and private budgets.

Chronic Disorder in America: Chronic diseases are ongoing, generally incurable illnesses or conditions, such as heart disease, asthma, cancer, and diabetes. These diseases are often preventable, and frequently manageable through early detection, improved diet, exercise, and treatment therapy. Chronic diseases are the leading cause of death and disability in the United States. 133 million Americans 45% of the population have at least one chronic disease. Chronic diseases are responsible for seven out of every 10 deaths in the U.S., killing more than 1.7 million Americans every year. Chronic diseases can be disabling and reduce a person’s quality of life, especially if left undiagnosed or untreated.

Chronic Disorder in Asia-Pacific: Many countries in the Asia-Pacific region will experience rapidly ageing societies over the next few decades. Globally, the number of people aged 60 years and over is expected to double by 2050. The projected increase in the number of older people, along with the rapid rise in the prevalence of lifestyle risk factors, will contribute to the increase in no communicable diseases (NCDs). A high proportion of total deaths across the Asia-Pacific region are caused by NCDs, particularly in South-East Asia and the Western Pacific. NCD rates, both morbidity and mortality, are projected to increase dramatically over the next few decades. While risk factors stretch back across the life span, the prevalence and treatment of most NCD conditions occur among older people. NCDs develop progressively over the life span with ever-increasing impacts on functional capacities. Major NCDs include cardiovascular diseases, diabetes, cancers and chronic respiratory diseases. These generally have strong social determinants and numerous shared risk factors, many of which are amenable to prevention and improvement throughout life.

Global Analysis: NIH participates in the Global Alliance for Chronic Diseases (GACD) , a collection of publicly funded research agencies that supports innovative research collaborations to address the prevention and treatment of chronic diseases in vulnerable populations.

GACD Primary and Secondary Prevention of Cancer

The current GACD funding call focuses on implementation research proposals for the primary and secondary prevention of cancer in low- and middle-income countries (LMICs), and in populations facing conditions of vulnerability in high-income countries.

NIH funding opportunity supporting this call for applications: Notice of Special Interest (NOSI): Dissemination and Implementation Science for Cancer Prevention and Control in Low Resource Environments (NOT-CA-20-025) Submit applications using one of the following NIH funding opportunity announcements (FOAs). Applies to application due dates from June 5, 2020 through May 8, 2022.

• International Conference on Chronic Disorder and Infectious Diseases

  November 23-24, 2020

  Madrid, Spain